The recombinant human pentraxin-2 (PTX-2) drug is no longer listed in Roche’s R&D pipeline, and was previously in development for idiopathic pulmonary fibrosis (IPF), as well as Crohn’s disease.

The transaction includes an upfront fee of $150 million and will give BMS a worldwide licence for PRM-151, a recombinant form of human pentraxin-2 protein which is in development for the treatment ...

Nintendo Switch 2 is finally confirmed. After literal years of unverified rumors, dubious leaks and copious amounts of online speculation, Nintendo has lifted the lid on its next-generation ...

I joined the University of Sheffield in 2002 as a Senior Clinical Lecturer in Cardiology and subsequently became Professor of Cardiology in January 2011. I am Clinical Lead for the Cardiovascular ...

The Last of Us Part 2 Remastered will release on April 3, 2025, for players on PC. As revealed during The Game Awards 2024, the Ellie-focused sequel heads to PC with a few upgrades beyond the ...

In this research group, the research areas of global surgery and reconstructive plastic surgery meet. The research is to a large extent focused on the development and improvement of surgical health ...